Regeneron Pharmaceuticals (REGN) Inventory (2012 - 2026)
Regeneron Pharmaceuticals' quarterly Inventory came in at $3.1 billion in Q1 2026, down 2.78% year-on-year from $3.2 billion in Q1 2025, and down 3.04% quarter-over-quarter from $3.2 billion in Q4 2025.
Regeneron Pharmaceuticals has reported Inventory for 15 years, with the latest figure at $3.1 billion in Q1 2026.
- For the quarter ending Q1 2026, Inventory fell 2.78% year-over-year to $3.1 billion; the trailing twelve-month figure through Mar 2026 stood at $3.1 billion (down 2.78% YoY), and the FY2025 full-year result was $3.2 billion, up 3.68% from the prior year.
- Inventory for Q1 2026 stood at $3.1 billion, down from $3.2 billion in the prior quarter.
- The five-year high for Inventory was $3.3 billion in Q3 2025, with the low at $2.0 billion in Q1 2022.
- Average Inventory over 5 years is $2.7 billion, with a median of $2.7 billion recorded in 2024.
- Peak annual rise in Inventory reached 23.09% in 2022, while the deepest fall reached 8.0% in 2022.
- Tracing REGN's Inventory over 5 years: stood at $2.4 billion in 2022, then gained by 7.44% to $2.6 billion in 2023, then rose by 19.64% to $3.1 billion in 2024, then increased by 3.68% to $3.2 billion in 2025, then decreased by 3.04% to $3.1 billion in 2026.
- The last three Inventory figures came in at $3.1 billion (Q1 2026), $3.2 billion (Q4 2025), and $3.3 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 32.00 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.77 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 3.10 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 84.03 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.10 Bn |
| Dec 31, 2025 | 3.20 Bn |
| Sep 30, 2025 | 3.25 Bn |
| Jun 30, 2025 | 3.21 Bn |
| Mar 31, 2025 | 3.19 Bn |
| Dec 31, 2024 | 3.09 Bn |
| Sep 30, 2024 | 3.02 Bn |
| Jun 30, 2024 | 2.87 Bn |
| Mar 31, 2024 | 2.71 Bn |
| Dec 31, 2023 | 2.58 Bn |
| Sep 30, 2023 | 2.56 Bn |
| Jun 30, 2023 | 2.51 Bn |
| Mar 31, 2023 | 2.42 Bn |
| Dec 31, 2022 | 2.40 Bn |
| Sep 30, 2022 | 2.41 Bn |
| Jun 30, 2022 | 2.22 Bn |
| Mar 31, 2022 | 1.99 Bn |
| Dec 31, 2021 | 1.95 Bn |
| Sep 30, 2021 | 2.05 Bn |
| Jun 30, 2021 | 1.98 Bn |
| Mar 31, 2021 | 2.16 Bn |
| Dec 31, 2020 | 1.92 Bn |
| Sep 30, 2020 | 1.80 Bn |
| Jun 30, 2020 | 1.64 Bn |
| Mar 31, 2020 | 1.48 Bn |
| Dec 31, 2019 | 1.42 Bn |
| Sep 30, 2019 | 1.34 Bn |
| Jun 30, 2019 | 1.32 Bn |
| Mar 31, 2019 | 1.21 Bn |
| Dec 31, 2018 | 1.15 Bn |
| Sep 30, 2018 | 1.04 Bn |
| Jun 30, 2018 | 928.55 Mn |
| Mar 31, 2018 | 820.40 Mn |
| Dec 31, 2017 | 726.10 Mn |
| Sep 30, 2017 | 641.59 Mn |
| Jun 30, 2017 | 554.32 Mn |
| Mar 31, 2017 | 466.58 Mn |
| Dec 31, 2016 | 399.36 Mn |
| Sep 30, 2016 | 345.62 Mn |
| Jun 30, 2016 | 316.07 Mn |
| Mar 31, 2016 | 303.29 Mn |
| Dec 31, 2015 | 238.58 Mn |
| Sep 30, 2015 | 190.67 Mn |
| Jun 30, 2015 | 171.27 Mn |
| Mar 31, 2015 | 133.86 Mn |
| Dec 31, 2014 | 128.86 Mn |
| Sep 30, 2014 | 120.32 Mn |
| Jun 30, 2014 | 109.90 Mn |
| Mar 31, 2014 | 86.55 Mn |
| Dec 31, 2013 | 70.35 Mn |
| Dec 31, 2012 | 28.64 Mn |